Tag: our research

As part of the Cancer Tech Accelerator, we’ve awarded Neurolase £50,000 to advance a laser-based tool that could help make brain tumour surgery more precise.

Artificial intelligence (AI) could help better inform treatment planning for meningioma, our researchers have found.

Emma Neason explains why she decided to join our Lay Advisory Board – a group of people with lived experience of brain tumours who help inform our research funding decisions.

We are funding two ambitious new pilot studies designed to spark progress in how we diagnose, monitor and treat brain tumours.

The Brain Tumour Charity has received an incredibly generous gift in memory of Gilly Lee, who passed away from glioblastoma in 2019.

We are pleased to announce the two researchers who have been awarded the Junior Fellowship grant – the second award in our Future Leaders programme!

Our Future Leader, Dr Chris Mount, has just opened his own lab at Massachusetts General Hospital.

New research suggests that immune cells in low grade gliomas may help them survive, providing insight that could lead to new treatments for children with these tumours.

Researchers have pinpointed a new biomarker that could help doctors more accurately predict the behaviour of meningiomas.

For the first time, The Brain Tumour Charity has collaborated with the Grace Kelly Childhood Cancer Trust as a funding partner, investing nearly £50,000 into research on paediatric brain tumours.

We’re excited to announce our investment of nearly £1.2 million into new translational research projects that aim to speed up the journey from lab discoveries to clinical treatment.

For the first time, The Brain Tumour Charity hosted a two-day event which brought together all 13 researchers that have been funded by our Future Leaders programme.

The Brain Tumour Charity has partnered with Worldwide Cancer Research to co-fund research into Diffuse Midline Glioma (DMG), investing £160,000 as part of a joint £400,000 commitment to tackle this devastating childhood brain cancer.

Our Future Leader, Dr Ángel Álvarez-Prado, is now leading his own research group at the Luxembourg Institute of Health.

We are pleased to introduce two more researchers who have been awarded our latest Expanding Theories grant!

In 2022, Professor Petra Hamerlik was appointed as The Brain Tumour Charity’s Chair of Translational Neuro-oncology, at the University of Manchester’s Cancer Research Centre.

Research we’re funding in partnership with The Oli Hilsdon Foundation at University College London is using advanced brain mapping to reveal how glioblastoma spreads and resists treatment, providing insight for potential new treatments.

This year has been an exciting year for our research. Read more as we share some of 2024’s best bits.

Involvement volunteer Baljit Ahluwalia lost her mother, Harbans Kaur Walia, to glioblastoma in 2020.

Bryony Powell knew very little about brain tumours before her fiancé, Catherine Roberts, was diagnosed with a glioblastoma in April 2018.

We are pleased to announce the two researchers who have been awarded our latest Expanding Theories grant!

The biennial CRUK Brain Tumour Conference returned to London for 2024.

Researchers in Newcastle have found a key genetic variation in medulloblastomas that may pave the way for more effective targeted treatments.

We’re proud to announce the latest recipients of our Future Leaders grants that’ve been awarded for their innovative new research projects.